TABRECTA 200 mg/1

TABRECTA 200 mg is a film-coated tablet containing capmatinib, used for targeted therapy. This medication is designed to interact with specific proteins in the body, supporting treatment for certain conditions.

TABRECTA 200 mg is primarily used in targeted therapy to address conditions related to specific protein interactions. It is often prescribed for patients who have particular genetic markers that respond to capmatinib. The medication works by inhibiting certain proteins, which can help manage symptoms and slow disease progression. What is TABRECTA used for? It is typically used in cases where other treatments may not be effective, providing a tailored approach to therapy.

Common effects of TABRECTA 200 mg may include gastrointestinal issues such as nausea or diarrhea. Some users might experience fatigue or skin reactions. These effects vary among individuals and are not experienced by everyone. It is important to monitor any changes and consult a healthcare provider if concerns arise.

TABRECTA 200 mg should be handled with care, following the prescribed dosage and administration guidelines. It is essential to store the medication properly and avoid sharing it with others. Patients should inform their healthcare provider about any pre-existing conditions or other medications they are taking to ensure safe usage.

TABRECTA 200 mg may interact with certain medications, including those that affect liver enzymes. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances that affect liver function should be used with caution while taking this medication.